newsfilter
← Latest News
GlobeNewswire·

Chinook Therapeutics Provides Business Update and Reports First Quarter 2022 Financial Results

SEATTLE, May 12, 2022 (GLOBE NEWSWIRE) -- Chinook Therapeutics, Inc. (NASDAQ:KDNY), a biopharmaceutical company focused on the discovery, development and commercialization of precision medicines for kidney diseases, today provided a business update and